Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study
by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,
Updated on: July 10,2024
0
Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study
by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,
Updated on:July 10,2024
0